https://biotechmorning.com/news/atacicept-iga-nephropathy-fda-decision Biotech Morning en 2026-07-03T14:25:50.614Z The Drug That Failed in Lupus Just Might Save Your Kidneys https://biotechmorning.com/news/fda-peptide-panel-conflicts-of-interest Biotech Morning en 2026-07-03T14:24:54.282Z The FDA Panel That Might Regulate Itself Into a Payday https://biotechmorning.com/news/roche-divarasib-beats-lumakras-krazati-kras-g12c Biotech Morning en 2026-07-03T14:23:59.371Z Roche Just Beat the KRAS Kings at Their Own Game https://biotechmorning.com/news/deaf-toddlers-hearing-gene-therapy-sensorion Biotech Morning en 2026-07-03T14:23:02.404Z These Deaf Toddlers Are Starting to Hear for the First Time https://biotechmorning.com/news/macrogenics-sells-factory-bora-pharmaceuticals Biotech Morning en 2026-07-03T14:22:14.205Z MacroGenics Just Sold Its Factory. That's Weirder Than It Sounds. https://biotechmorning.com/news/united-therapeutics-thymmune-thymus-acquisition Biotech Morning en 2026-07-03T14:21:19.963Z United Therapeutics Just Bought a Thymus. Yes, Really. https://biotechmorning.com/news/biotech-billion-dollar-shopping-spree-has-a-catch Biotech Morning en 2026-07-03T14:20:28.599Z Biotech's Billion-Dollar Shopping Spree Has a Catch https://biotechmorning.com/news/ipsen-two-acquisitions-one-week-memo-kartos Biotech Morning en 2026-07-03T14:19:32.564Z Ipsen Just Spent $2.5 Billion in One Week. What Are They Building? https://biotechmorning.com/news/bridgebio-billion-dollar-preferred-equity-sixth-street-kkr Biotech Morning en 2026-07-03T14:18:38.077Z Wall Street's Biggest Names Just Bet $1 Billion on One Biotech